Skip to main content
. 2018 May 21;84(6):1269–1279. doi: 10.1093/neuros/nyy179

TABLE 3.

Clinical Parameters at the Time of CBF-Measurement

Parameter CBF1 (n = 12) CBF2 (n = 12) P-value
ICP (cmH20; n = 10) 12.7 ± 6 13.7 ± 3 .96
CPP (mmHg; n = 10) 67.3 ± 10 73.4 ± 11 .33
MAP (mmHg) 86.6 ± 10 92.8 ± 12 .25
Propofol 20 mg/mL (mL/h) 15.3 ± 7 15.2 ± 8 .95
Remifentanil 100 μg/mL (mL/h) 5.0 ± 4 5.5 ± 4 .22
NE 40 μg/mL (mL/h) 7.2 ± 6 5.8 ± 4 .34
pCO2 (kPa) 5.4 ± 0.3 5.3 ± 0.5 .13
pO2 (kPa) 13.0 ± 2 14.2 ± 2 .39

ICP, intracranial pressure; CPP, cerebral perfusion pressure; MAP, mean arterial blood pressure; NE, norepinephrine; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen

All data presented as means ± SD. P-values from Student's t-test.